Canada markets open in 8 hours 48 minutes

Emerald Health Therapeutics, Inc. (EMH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3350+0.0100 (+3.08%)
At close: 3:59PM EST
Full screen
Previous Close0.3250
Open0.3500
Bid0.3300 x 0
Ask0.3350 x 0
Day's Range0.3250 - 0.3500
52 Week Range0.1200 - 0.5300
Volume343,508
Avg. Volume756,222
Market Cap68.684M
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-0.6960
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Emerald Health Therapeutics to Close Greater Vancouver Production Facility
    Newsfile

    Emerald Health Therapeutics to Close Greater Vancouver Production Facility

    Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will cease operations at its cannabis production facility in Greater Vancouver, British Columbia effective March 31, 2021 and will consider strategic alternatives for this facility. "Closing our Greater Vancouver production facility is part of Emerald's revised business strategy and transition away from the value segment of the cannabis market toward science-driven product ...

  • Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans
    Newsfile

    Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans

    Vancouver, British Columbia--(Newsfile Corp. - February 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received from Village Farms International Inc. $19.9M plus $621,534.25 in interest, representing full repayment of the promissory note issued by Village Farms to Emerald as part of its purchase of Emerald's interest in the Pure Sunfarms joint venture which closed in November 2020. This was the final payment due as part of this transaction. "After ...

  • Emerald Health Therapeutics Promotes Two Executives to Senior Roles
    Newsfile

    Emerald Health Therapeutics Promotes Two Executives to Senior Roles

    Vancouver, British Columbia--(Newsfile Corp. - February 5, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has promoted Orville Bovenschen to the position of Senior Vice President, Operations and Rebecca Wong to Senior Vice President, Quality & Regulatory Affairs.Mr. Bovenschen has over 16 years of progressive experience in financial management, project and operations management, and strategy development and operational planning, including risk management. With Emerald since 2017, he has overseen ...